Angiotensin-II-receptor inhibitors in pregnancy.
Lambot
M A
MA
Vermeylen
D
D
Noël
J C
JC
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000015:Abnormalities, Multiple / Q000139:chemically induced* / Q000175:diagnosis; D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002585:Cesarean Section; D005260:Female; D005313:Fetal Death / Q000139:chemically induced*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007668:Kidney / Q000002:abnormalities; D007866:Leg / Q000002:abnormalities; D019808:Losartan / Q000009:adverse effects*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011262:Pregnancy Trimester, Second; D018566:Pregnancy, High-Risk; D016216:Ultrasonography, Prenatal
D000959:Antihypertensive Agents; D019808:Losartan